| NOBEL Pharma Schweiz AG - Sitagliptin Metformin NOBEL 50 mg/500 mg, Filmtabletten | | 68967 | | 01 | | Sitagliptin Metformin NOBEL 50 mg/500 mg | | Filmtabletten | | A10BD07 | | Metformine et Sitagliptine | | 28.12.2023 | | |
| | Composition | | sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum 56.69 mg, metformini hydrochloridum 500 mg, povidonum K 30, cellulosum microcristallinum, crospovidonum, natrii stearylis fumaras corresp. natrium 0.765 mg, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, E 172 (flavum), E 172 (rubrum), E 172 (nigrum), pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | Principe actif | Concentr. |
|---|
| Metformine Hydrochloride | 500 mg | | Sitagliptine | 50 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | (Nigrum) | | | | (Rubrum) | | | | Cellulosum Microcristallinum | | | | Crospovidonum | | | | E 171 | | color. | | E 172 | | color. | | Macrogol | 3350 | | | Natrii Stearylis Fumaras | | | | Poly(Alcohol Vinylicus) | | Überzug | | Povidonum K | 30 | | | Pro Compresso Obducto | | | | Talcum | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 56 | DDP | DDP | B | | Non | | 002 | 2 x 98 | DDP | DDP | B | | Non |
|
|
